Related Experiment Videos
Secondary Bone Defect in Neuromuscular Diseases in Childhood: A Longitudinal "Muscle-Bone Unit" Analysis
C Ribstein1, D Courteix2,3, N Rabiau1,4
1Centre de compétence des neuropathies de cause rare et centre de compétence des pathologies neuro-musculaires, Service de Génétique Médicale, Hôpital Estaing, Clermont-Ferrand, France.
Neuropediatrics
|July 7, 2018
Summary
Neuromuscular diseases often cause bone defects, leading to osteopenia in most patients. Regular bone monitoring is crucial for managing fracture risk in these conditions.
Area of Science:
- Bone Metabolism
- Neuromuscular Diseases
- Endocrinology
Background:
- Neuromuscular diseases (NMDs) are associated with secondary bone defects.
- Understanding the relationship between muscle and bone health is critical for patient management.
Purpose of the Study:
- To evaluate bone defects in patients with Duchenne muscular dystrophy (DMD), limb-girdle muscular dystrophy (LGMD), Becker muscular dystrophy (BeMD), and spinal muscular atrophy (SMA).
- To assess the longitudinal changes in bone mineral density (BMD) and related markers in these patient groups.
Main Methods:
- A 7-year longitudinal study involving patients with DMD, LGMD, BeMD, and SMA.
- Yearly osteodensitometries to assess body composition and BMD.
- Analysis of bone markers, leptin levels, and correlation with muscle mass and fat mass.
Main Results:
- Most patients, except those with BeMD, developed osteopenia over the study period.
- BMD increased with age in BeMD and SMA patients, but decreased in DMD/LGMD patients.
- A significant correlation was observed between muscle mass and bone tissue, and glucocorticoids negatively impacted bone health.
Conclusions:
- This study confirms a secondary bone defect in NMDs, highlighting the functional relationship between muscle and bone.
- Regular bone follow-up is recommended for patients with NMDs to prevent fracture risk.
- Adipose tissue appears to play a role in bone remodeling within the context of NMDs.